Search

Search results

136 results found

Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson’s disease.

Publication: Journal Article

Kase, H, S Aoyama, M Ichimura, K Ikeda, A Ishii, T Kanda, K Koga, and . 2003. “Progress in Pursuit of Therapeutic A2A Antagonists: the Adenosine A2A Receptor Selective Antagonist KW6002: Research and Development Toward a Novel Nondopaminergic Therapy for Parkinson’s Disease.”. Neurology.

Randomized trial of the adenosine A2A receptor antagonist istradefylline in advanced PD. Neurology 2003;61:297-303.

Publication: Journal Article

Hauser, RA, JP Hubble, and DD Truong. 2003. “Randomized Trial of the Adenosine A2A Receptor Antagonist Istradefylline in Advanced PD. Neurology 2003;61:297-303.”. Neurology.

2025 HFpEF SUMMIT REGISTRATION OPEN

News: November 18, 2024

The HFpEF Summit is a bi-annual, two-day meeting which brings together internationally recognized leaders in the areas of clinical, translational and biological studies of heart failure with preserved ejection fraction (HFpEF). This summit is focused on the latest insights and innovations for...

Dr. Blair is a Co-Investigator of new $3.75 million NIH award to study links between COVID and Alzheimer's disease

News: October 25, 2024

Driving safety in Parkinson’s disease. Neurology 2002;59:1787-1788.

Publication: Journal Article

Zesiewicz, TA, CR Cimino, AR Malek, N Gardner, PL Leaverton, PB Dunne, and RA Hauser. 2002. “Driving Safety in Parkinson’s Disease. Neurology 2002;59:1787-1788.”. Neurology.

2024 Festivals

News: November 23, 2024

Halloween, Diwali, Birthdays ...Many reasons to celebrate